Scienza e Tecnologia
Continuous Bioprocessing Market Worth $599 Million | MarketsandMarkets
By product, the continuous bioprocessing market has been categorized as chromatography systems & consumables; filtration systems & devices; bioreactors; cell culture media, cell lines, buffers, and reagents; and other products. The chromatography systems and consumables segment held the largest share of the global continuous bioprocessing market in 2022. With an increased demand for biologics, the need for intensification of the upstream and downstream process to boost productivity and lower manufacturing costs has increased. This has created a demand for multicolumn chromatography, which can be effectively operated continuously to increase output and decrease resin & buffer usage, thus ensuring optimal operations.
Based on application, the continuous bioprocessing market is segmented into monoclonal antibodies, vaccines, cell and gene therapy, other applications. In 2022, the monoclonal antibodies segment accounted for the largest share of the continuous bioprocessing market. This can be attributed to the increasing demand for single use bioreactors in the manufacturing of mAbs due to low cost, low workforce requirements, and reduction in time-consuming changeover procedures and validation.
The continuous bioprocessing market is segmented into upstream & downstream bioprocesses. downstream bioprocess is the largest process segment of the continuous bioprocessing market. Advancements in downstream technologies such as Single-pass Tangential Flow Filtration (SPTFF) and multicolumn chromatography is expected to drive the segment growth during the forecast period.
The continuous bioprocessing market is segmented into North America , Europe , the Asia Pacific (APAC), Latin America (LATAM), and the Middle East and Africa (MEA). North America regional market held a substantial share of the continuous bioprocessing market owing to the presence of a well-established biopharmaceutical industry and major players operating in the continuous bioprocessing market.
Key players in the continuous bioprocessing market include Danaher Corporation (US), Sartorius AG ( Germany ), Thermo Fisher Scientific Inc. (US), Repligen Corporation (US), Merck KGaA ( Germany ), 3M Company (US), Getinge AB ( Sweden ), Eppendorf SE ( Germany ), Corning Incorporated (US), Entegris (US), FUJIFILM Holdings Corporation ( Japan ), Meissner filtration products, Inc. (US), Kühner AG ( Switzerland ), Esco Lifesciences Group ( Singapore ), SATAKE MultiMix Corporation ( Japan ), Bionet ( Spain ), Stobbe Group ( Switzerland ), bbi-biotech GmbH ( Germany ), OmniBRx Biotechnologies ( India ), Cell Culture Company, LLC (US), Pierre Guérin ( France ), Solida Biotech GmbH ( Germany ), Zellwerk GmbH ( Germany ), 3D Biotek, LLC (US), FiberCell Systems Inc. (US), among others.
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall continuous bioprocessing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
- Global Forecasts to 2028
- Global Forecasts to 2028
- Global Forecasts to 2028
- Global Forecasts to 2028
- Global Forecasts to 2028
MarketsandMarkets™ has been recognized as one of , as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/continuous-bioprocessing-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/continuous-bioprocessing.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/continuous-bioprocessing-market-worth-599-million--marketsandmarkets-301997060.html